BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 24065423)

  • 21. Role of creatine phosphate as a myoprotective agent during coronary artery bypass graft in elderly patients.
    Guo-han C; Jian-hua G; Xuan H; Jinyi W; Rong L; Zhong-min L
    Coron Artery Dis; 2013 Jan; 24(1):48-53. PubMed ID: 23114287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Granulocyte- and monocyte-platelet adhesion index in coronary and peripheral blood after extracorporeal circulation and reperfusion.
    Sbrana S; Buffa M; Bevilacqua S; Spiller D; Parri MS; Gianetti J; De Filippis R; Clerico A
    Cytometry B Clin Cytom; 2007 May; 72(3):215-22. PubMed ID: 17133378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutrophil depletion reduces myocardial reperfusion morbidity.
    Palatianos GM; Balentine G; Papadakis EG; Triantafillou CD; Vassili MI; Lidoriki A; Dinopoulos A; Astras GM
    Ann Thorac Surg; 2004 Mar; 77(3):956-61. PubMed ID: 14992906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystalloid versus cold blood cardioplegia and cardiac troponin I release.
    Pichon H; Chocron S; Alwan K; Toubin G; Kaili D; Falcoz P; Latini L; Clement F; Viel JF; Etievent JP
    Circulation; 1997 Jul; 96(1):316-20. PubMed ID: 9236451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leukocyte-depleted blood cardioplegia reduces cardiac troponin T release in patients undergoing coronary artery bypass grafting.
    Hiramatsu Y; Koishizawa T; Matsuzaki K; Enomoto Y; Sakakibara Y
    Jpn J Thorac Cardiovasc Surg; 2000 Oct; 48(10):625-31. PubMed ID: 11080949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies of controlled reperfusion after ischemia. XXII. Reperfusate composition: effects of leukocyte depletion of blood and blood cardioplegic reperfusates after acute coronary occlusion.
    Kofsky ER; Julia PL; Buckberg GD; Quillen JE; Acar C
    J Thorac Cardiovasc Surg; 1991 Feb; 101(2):350-9. PubMed ID: 1992246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardioprotective effect of cold-blood cardioplegia enriched with N-acetylcysteine during coronary artery bypass grafting.
    Koramaz I; Pulathan Z; Usta S; Karahan SC; Alver A; Yaris E; Kalyoncu NI; Ozcan F
    Ann Thorac Surg; 2006 Feb; 81(2):613-8. PubMed ID: 16427861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leukocyte depleting filter attenuates myocardial injury during elective coronary artery bypass surgery.
    Koskenkari J; Rimpiläinen J; Biancari F; Surcel HM; Kaukoranta P; Kiviluoma K; Ala-Kokko T; Juvonen T
    Scand Cardiovasc J; 2005 Dec; 39(6):358-68. PubMed ID: 16352489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leukocyte-depleted terminal blood cardioplegia provides superior myocardial protective effects in association with myocardium-derived nitric oxide and peroxynitrite production for patients undergoing prolonged aortic crossclamping for more than 120 minutes.
    Hayashi Y; Sawa Y; Fukuyama N; Miyamoto Y; Takahashi T; Nakazawa H; Matsuda H
    J Thorac Cardiovasc Surg; 2003 Dec; 126(6):1813-21. PubMed ID: 14688692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Release of cardiac troponin I in antegrade crystalloid versus cold blood cardioplegia.
    Hendrikx M; Jiang H; Gutermann H; Toelsie J; Renard D; Briers A; Pauwels JL; Mees U
    J Thorac Cardiovasc Surg; 1999 Sep; 118(3):452-9. PubMed ID: 10469959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of different cardioplegic solutions on nitric oxide release from coronary vasculature in diabetic patients undergoing coronary artery bypass surgery.
    Karaca P; Yurtseven N; Enç Y; Aksoy T; Sokullu O; Bilgen F; Canik S
    Anadolu Kardiyol Derg; 2006 Dec; 6(4):347-51. PubMed ID: 17162282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood cardioplegia supplementation with the sodium-hydrogen ion exchange inhibitor cariporide to attenuate infarct size and coronary artery endothelial dysfunction after severe regional ischemia in a canine model.
    Muraki S; Morris CD; Budde JM; Zhao ZQ; Guyton RA; Vinten-Johansen J
    J Thorac Cardiovasc Surg; 2003 Jan; 125(1):155-64. PubMed ID: 12538999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced cytokines release and myocardial damage in coronary artery bypass patients due to L-arginine cardioplegia supplementation.
    Colagrande L; Formica F; Porta F; Martino A; Sangalli F; Avalli L; Paolini G
    Ann Thorac Surg; 2006 Apr; 81(4):1256-61. PubMed ID: 16564254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD11b may be a less satisfactory indicator for cardiac ischemia-reperfusion injury in coronary artery bypass graft surgery with cardiopulmonary bypass than cardiac troponin I.
    Li C; Zhao W; Wu K; Zhang J; Jia N
    J Clin Anesth; 2005 May; 17(3):158-62. PubMed ID: 15896579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of myocardial metabolism with microdialysis during bypass surgery with cold blood- or Calafiore cardioplegia.
    Pöling J; Rees W; Mantovani V; Klaus S; Bahlmann L; Ziaukas V; Hübner N; Warnecke H
    Eur J Cardiothorac Surg; 2006 Oct; 30(4):597-603. PubMed ID: 16901714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retrograde versus antegrade delivery of cardioplegic solution in myocardial revascularization. A clinical trial in patients with three-vessel coronary artery disease who underwent myocardial revascularization with extensive use of the internal mammary artery.
    Noyez L; van Son JA; van der Werf T; Knape JT; Gimbrère J; van Asten WN; Lacquet LK; Flameng W
    J Thorac Cardiovasc Surg; 1993 May; 105(5):854-63. PubMed ID: 8487564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardial protection during elective coronary artery bypass grafting using high-dose insulin therapy.
    Albacker TB; Carvalho G; Schricker T; Lachapelle K
    Ann Thorac Surg; 2007 Dec; 84(6):1920-7; discussion 1920-7. PubMed ID: 18036907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bolus injection of adenosine before cardioplegic induction improves postischemic global function in coronary artery bypass grafting.
    Chen CH; Kang PL; Chang TH; Lo A; Ye XD; Lee MC; Liu K
    Acta Anaesthesiol Taiwan; 2005 Dec; 43(4):197-204. PubMed ID: 16450593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficiency of L-arginine enriched cardioplegia and non-cardioplegic reperfusion in ischemic hearts.
    Kiziltepe U; Tunçtan B; Eyileten ZB; Sirlak M; Arikbuku M; Tasoz R; Uysalel A; Ozyurda U
    Int J Cardiol; 2004 Oct; 97(1):93-100. PubMed ID: 15336814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergency coronary artery surgery after failed PTCA: myocardial protection with continuous coronary perfusion of beta-blocker-enriched blood.
    Hekmat K; Clemens RM; Mehlhorn U; Geissler HJ; Kuhn-Régnier F; de Vivie ER
    Thorac Cardiovasc Surg; 1998 Dec; 46(6):333-8. PubMed ID: 9928853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.